Metsera

Biotechnology Research • United States • 101-200 Employees

Company overview

Headquarters	United States
Phone number	+12127846595
Website	metsera.com
NAICS	541714
Employees	101-200
Socials

Key Contact at Metsera

Whit Bernard

Chief Executive Officer

Mobile @metsera.com

Metsera Email Formats

Metsera uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@metsera.com), used 57% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@metsera.com	57%
{first name}.{last name}	john.doe@metsera.com	41.8%
{first initial}{last name}	jdoe@metsera.com	1.3%

About Metsera

Metsera is a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases. Metsera is advancing a broad portfolio of oral and injectable incretin, non-incretin and combination therapies with potential best-in-class profiles to address multiple therapeutic targets and meet the future needs of a rapidly evolving weight loss treatment landscape. Founded in 2022 by Population Health Partners and ARCH Venture Partners, Metsera has raised $290 million in financing from leading healthcare investors and is based in New York City.

Metsera revenue & valuation

Annual revenue	$10,400,000
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$33,200,000
Total funding	$215,000,000